Breathe Well Live Well
Conditions: Asthma; Moderate Asthma
Interventions: Drug: REGN3500; Drug: Placebo
Sponsors: Regeneron Pharmaceuticals; Sanofi
Not yet recruiting – verified December 2016
View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days
Conditions: Healthy Volunteers; Asthma
Interventions: Drug: RP3128; Drug: Placebo
Sponsor: Rhizen Pharmaceuticals SA
Recruiting – verified November 2016
View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days
Conditions: Allergic Rhinitis; Rhinoconjunctivitis; Asthma
Intervention: Biological: Allergovac Poliplus
Sponsor: BIAL Industrial Farmacéutica S.A.
Not yet recruiting – verified July 2016
View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days
Conditions: Asthma; Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Drug: AZD7594 inhalation powder (200 ?g); Drug: AZD7594 inhalation powder (400 ?g); Drug: AZD7594 pressurized inhalation suspension (200 ?g); Drug: AZD7594 placebo inhalation powder; Drug: AZD7594 placebo pressurized inhalation suspension
Sponsor: AstraZeneca
Not yet recruiting – verified December 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Conditions: Asthma (Part 1); COPD (Part 2)
Interventions: Drug: Dose 1, AZD8871 50 ?g (Part 1); Drug: Dose 2, AZD8871 100 ?g (Part 1); Drug: Dose 3, AZD8871 300 ?g (Part 1); Drug: Dose 4, AZD8871 600 µg (Part 1); Drug: Dose 5, AZD8871 1200 µg (Part 1); Drug: Dose 6, AZD8871 1800 ?g (Part 1); Drug: Placebo, AZD8871 placebo (Part 1); Drug: Treatment A, AZD8871 dose A (Part 2); Drug: Treatment B, AZD8871 dose B (Part 2); Drug: Treatment C, Indacaterol 150 ?g (Part 2); Drug: Treatment D, Tiotropium 18 ?g (Part 2)
Sponsor: AstraZeneca
Not yet recruiting – verified October 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Asthma
Interventions: Drug: Treatment A: Fp MDPI; Drug: Treatment B: FS MDPI; Drug: Treatment C Flovent; Drug: Treatment D: Advair
Sponsor: Teva Branded Pharmaceutical Products, R&D Inc.
Not yet recruiting – verified May 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Conditions: Rhinitis; Rhinoconjunctivitis; Asthma
Interventions: Biological: DP/MG/14-1; Biological: DP/MG/14-2
Sponsor: Laboratorios Leti, S.L.
Recruiting – verified January 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Asthma
Interventions: Drug: NEUMOTEROL 400 (BFF 400/12 mcg) single capsule inhaler; Drug: SYMBICORT forte (BFF 320/9mcg) TURBUHALER inhaler; Drug: NEUMOTEX 400 (Budesonide 400 mcg); Drug: Salbutamol 100 mcg pMDI
Sponsors: GlaxoSmithKline; Laboratorios Phoenix
Not yet recruiting – verified September 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Asthma
Interventions: Drug: PBF-680; Drug: Placebo
Sponsors: Fundació Institut de Recerca de l’Hospital de la Santa Creu i Sant Pau; Palo Biofarma, S.L
Recruiting – verified August 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Asthma
Intervention: Drug: Laninamivir octanoate
Sponsors: Biota Scientific Management Pty Ltd; Department of Health and Human Services
Recruiting – verified December 2013
View full post on ClinicalTrials.gov: asthma | received in the last 14 days